Power Law company profile

Amylyx Pharmaceutical

Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2022 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.42B

Market cap · Apr/2026

Investors

17 investors on Amylyx Pharmaceutical's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

Series B+ 14 investors entered at this stage

Global footprint

Web traffic by country

13K monthly visits
across markets

🇺🇸 United States88.5%

🇮🇳 India8.5%

🇬🇧 United Kingdom3.1%

🇹🇷 Turkey2.3%

🏳️ Pakistan0.8%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo